Matthew M. Gosling
2012
In 2012, Matthew M. Gosling earned a total compensation of $807K as Senior Vice President and General Counsel at DepoMed, a 13% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $122,588 |
|---|---|
| Option Awards | $147,263 |
| Salary | $368,978 |
| Stock Awards | $164,970 |
| Other | $3,241 |
| Total | $807,040 |
Gosling received $369K in salary, accounting for 46% of the total pay in 2012.
Gosling also received $122.6K in non-equity incentive plan, $147.3K in option awards, $165K in stock awards and $3.2K in other compensation.
Rankings
In 2012, Matthew M. Gosling's compensation ranked 6,985th out of 11,487 executives tracked by ExecPay. In other words, Gosling earned more than 39.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,985 out of 11,487 | 39th |
Division Manufacturing | 2,502 out of 4,253 | 41st |
Major group Chemicals And Allied Products | 638 out of 1,203 | 47th |
Industry group Drugs | 438 out of 925 | 53rd |
Industry Pharmaceutical Preparations | 343 out of 700 | 51st |
Source: SEC filing on April 6, 2015.
Gosling's colleagues
We found four more compensation records of executives who worked with Matthew M. Gosling at DepoMed in 2012.